Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. En savoir plus sur Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn''s disease. En savoir plus sur A clinical decision support tool may help to optimise vedolizumab therapy in Crohn''s disease.